Masimo Corp (Masimo) is a medical technology company that develops, manufactures and markets non-invasive patient monitoring technologies, medical devices and sensors to improve patient care. The company’s proprietary technologies include signal extraction technology (SET) that helps detect life-threatening events; and rainbow SET platform. Its major products include patient monitors, pulse oximeters, central monitoring systems, specialty sensors, circuit boards, remote-alarms, and monitoring solutions. The company also markets products directly and through a network of distributors and original equipment manufacturers to hospitals, emergency medical service providers, home care providers, physician offices, veterinarians, long term care facilities and consumers. The company operates in North and South America, Europe, the Middle East, Africa, Asia, and Australia. Masimo is headquartered in Irvine, California, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
The report analyzes all pipeline products in development for the company Masimo Corp
The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
The report provides detailed description of products in development, technical specification and functions
The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
To formulate effective Research & Development strategies
Develop market-entry and market expansion strategies
Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Masimo Corp Company Overview
Masimo Corp Company Snapshot
Masimo Corp Pipeline Products and Ongoing Clinical Trials Overview
Masimo Corp – Pipeline Analysis Overview
Business Description
Masimo Corp - Key Facts
Masimo Corp - Major Products and Services
Masimo Corp Pipeline Products by Development Stage
Masimo Corp Ongoing Clinical Trials by Trial Status
Masimo Corp Pipeline Products Overview
Eve
Eve Product Overview
iSpO2 Rx
iSpO2 Rx Product Overview
LiDCO IM System
LiDCO IM System Product Overview
LiDCOrapid
LiDCOrapid Product Overview
LiDCOrapid Clinical Trial
Masimo Rainbow SET Pulse CO-Oximetry - RPVi
Masimo Rainbow SET Pulse CO-Oximetry - RPVi Product Overview
rainbow Super DCI-mini sensor - Continuous Measurement Version
rainbow Super DCI-mini sensor - Continuous Measurement Version Product Overview
Rainbow SuperSensor
Rainbow SuperSensor Product Overview
Root Iris Display Mobile App
Root Iris Display Mobile App Product Overview
Superset
Superset Product Overview
Masimo Corp - Key Competitors
Masimo Corp - Key Employees
Masimo Corp - Key Employee Biographies
Masimo Corp - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Masimo Corp, Recent Developments
May 29, 2024: Medable and Masimo Partner to Bring Best-in-Class Wearable Devices to Clinical Research, Capturing Rich Subjective and Objective Data
May 20, 2024: Masimo Receives Sustainability Seal of Approval from Practice Greenhealth
May 16, 2024: Masimo Receives Additional 510(k) Clearance For Stork Baby Monitoring System
May 09, 2024: Regulatory Clearance for Leo Cancer Care’s Upright Technology for Radiation Therapy
May 06, 2024: Masimo Receives FDA Clearance for Stork Over-the-Counter (OTC) Baby Monitoring System
Feb 14, 2024: Masimo Announces the First FDA-cleared “Over-the-Counter” Fingertip Pulse Oximeter
Feb 08, 2024: New Peer-Reviewed Study Finds That Masimo Set Pulse Oximetry Measures Accurately on Both Black and White People Even During Low Perfusion
Jan 17, 2024: Masimo Announces Reinstatement of Import Ban on Infringing Apple Watches
Dec 26, 2023: Masimo Receives 510(k) Clearance for Stork Baby Monitoring System
Dec 19, 2023: Masimo’s baby monitoring system receives US FDA clearance
Table 18: LiDCOrapid - Accuracy of Mini-Fluid Challenge Test in Predicting Fluid Responsiveness in Patients Undergoing Pulmonary Lobectomy with One-Lung Ventilation
Table 19: Masimo Rainbow SET Pulse CO-Oximetry - RPVi - Product Status